Atlas Trials

Renal and Systemic Effects of NCX4016 in Patients With Type 2 Diabetes and Early Nephropathy

Clinical trial NCT00157508 · TERMINATED

Trial details

NCT number
NCT00157508
Sponsor
Mario Negri Institute for Pharmacological Research
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Type 2 DiabetesEarly Nephropathy
Start date
2003-03-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.